These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20023202)

  • 21. Ductal carcinoma in situ (DCIS). A highly treatable breast cancer.
    Mayo Clin Womens Healthsource; 2009 Oct; 13(10):1-2. PubMed ID: 19727033
    [No Abstract]   [Full Text] [Related]  

  • 22. [Atypical epithelial hyperplasias, ductal and lobular carcinoma in situ. Treatment, follow-up and prognosis].
    Käresen R; Hagen S
    Tidsskr Nor Laegeforen; 1987 Mar; 107(9):859-60, 865. PubMed ID: 3035745
    [No Abstract]   [Full Text] [Related]  

  • 23. [Ductal carcinoma in situ of the breast (DCIS) under 40: a specific management?].
    Cutuli B
    Gynecol Obstet Fertil; 2008 Jun; 36(6):705-6. PubMed ID: 18539513
    [No Abstract]   [Full Text] [Related]  

  • 24. [New therapeutic perspectives in breast ductal carcinoma in situ].
    Ladekarl M; Grau C; Andersen J
    Ugeskr Laeger; 2001 Sep; 163(37):5014-7. PubMed ID: 11573374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How different terminology for ductal carcinoma in situ impacts women's concern and treatment preferences: a randomised comparison within a national community survey.
    McCaffery K; Nickel B; Moynihan R; Hersch J; Teixeira-Pinto A; Irwig L; Barratt A
    BMJ Open; 2015 Nov; 5(11):e008094. PubMed ID: 26525720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re: Trends in the treatment of ductal carcinoma in situ of the breast.
    Zorbas H; Luxford K; Evans A; Villanueva EV
    J Natl Cancer Inst; 2004 Aug; 96(16):1258; author reply 1259-60. PubMed ID: 15316063
    [No Abstract]   [Full Text] [Related]  

  • 27. [In situ carcinomas of the breast: clinical features and therapeutic strategies].
    Attene F; Scognamillo F; Trignano E; Meloni GB; Rubino C; Trignano M
    Ann Ital Chir; 2006; 77(1):3-10; discussion 10-2. PubMed ID: 16910353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is excision alone adequate treatment for low-risk ductal carcinoma-in-situ of the breast?
    Solin LJ
    J Clin Oncol; 2006 Mar; 24(7):1017-9. PubMed ID: 16461780
    [No Abstract]   [Full Text] [Related]  

  • 29. Mitigating overdiagnosis and overtreatment in breast cancer: what is the role of the pathologist?
    Calhoun BC; Livasy CA
    Arch Pathol Lab Med; 2014 Nov; 138(11):1428-31. PubMed ID: 24628451
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of in situ ductal cancers of the breast].
    Rochet Y
    Rev Fr Gynecol Obstet; 1991 Nov; 86(11):666-8. PubMed ID: 1664138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient education. Ductal carcinoma in situ.
    NSW Breast Cancer Institute
    Aust Fam Physician; 2005 Nov; 34(11):955. PubMed ID: 16299631
    [No Abstract]   [Full Text] [Related]  

  • 32. [Procedures of analytic morphometry in the monitoring of nuclear changes of breast ductal epithelium from normal to carcinoma].
    Giardina C; Serio G; Potente F; Pennella A; Lettini T; Di Tolve P; Ricco R; Pesce Delfino V
    Pathologica; 1992; 84(1094):97-100. PubMed ID: 1338654
    [No Abstract]   [Full Text] [Related]  

  • 33. Definition of precancerous and high-risk mammary lesions.
    Bégin LR
    Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 'Ductal carcinoma in situ of the breast' -- is it time to replace this term by 'ductal intraepithelial neoplasia of the breast'?
    Tavassoli FA; Sakorafas GH
    Onkologie; 2009 Apr; 32(4):218. PubMed ID: 19372721
    [No Abstract]   [Full Text] [Related]  

  • 35. Ductal carcinoma in situ: through a glass, darkly.
    Lagios MD; Silverstein MJ
    Ann Surg Oncol; 2008 Jan; 15(1):16-7. PubMed ID: 18043977
    [No Abstract]   [Full Text] [Related]  

  • 36. A critical appraisal of existing classification systems of epithelial hyperplasia and in situ neoplasia of the breast with proposals for future methods of categorization: where are we going?
    Ellis IO; Pinder SE; Lee AH; Elston CW
    Semin Diagn Pathol; 1999 Aug; 16(3):202-8. PubMed ID: 10490197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overcoming Barriers in Ductal Carcinoma In Situ Management: From Overtreatment to Optimal Treatment.
    Wright JL; Rahbar H; Obeng-Gyasi S; Carlos R; Tjoe J; Wolff AC
    J Clin Oncol; 2022 Jan; 40(3):225-230. PubMed ID: 34813345
    [No Abstract]   [Full Text] [Related]  

  • 38. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of vaccines for high-risk ductal carcinoma in situ of the breast.
    Czerniecki BJ; Roses RE; Koski GK
    Cancer Res; 2007 Jul; 67(14):6531-4. PubMed ID: 17638860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.